Clinical trial
Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer
NCT00003344 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00003344 |
|---|---|
| Title | Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer |
| Official title | Phase I-II Study of Weekly CPT-11 and Radiation Therapy for Unresectable or Locally Recurrent Large Bowel Cancer |
| Lead sponsor | Medical University of South Carolina, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Radiation |
| Interventions | irinotecan hydrochloride, radiation therapy |
| Enrollment | 49 |
| Start date | Aug 1, 1998 |
| Primary completion | Jan 1, 2000 |
| Completion | Jan 1, 2000 |
| First posted | Sep 13, 2004 |
| Last update posted | May 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: